Collection: Insulin Receptor Substrate 1 (IRS1)

Insulin Receptor Substrate 1 (IRS1) is a key adaptor protein involved in the insulin signaling pathway, crucial for regulating glucose metabolism, cell growth, and differentiation. Glycosylation of IRS1 enhances the protein's stability and functional interactions, making it relevant for various therapeutic and research applications. IRS1 glycopeptides have significant potential in the treatment of metabolic disorders, such as type 2 diabetes, by improving insulin signaling and glucose uptake in cells. Their role in cellular growth and differentiation also positions them as a potential target for addressing obesity and associated conditions. Additionally, their involvement in signaling pathways makes them valuable for studying cancer biology and developing targeted therapies for cancer treatment. Ongoing research aims to leverage their enhanced biological activity to improve therapeutic strategies and patient outcomes in these diverse medical areas.